| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |